Fusion Pharmaceuticals FUSN

$ 21.55 0.0%

Quarterly report 2024-Q1
added 05-07-2024

Fusion Pharmaceuticals Financial Statements 2011-2024 | FUSN

Annual Financial Statements Fusion Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.38 B	176 M	321 M	27 K	-	-	-	-	-	-	-	-	-
Shares	65.6 M	43.7 M	42.6 M	2.39 K	-	41.7 M	-	-	-	-	-	-	-
Historical Prices	21.1	4.03	7.53	11.7	-	-	-	-	-	-	-	-	-
Net Income	-94.9 M	-87.6 M	-81 M	-78.3 M	-16.2 M	-11.7 M	-6.26 M	-	-	-	-	-	-
Revenue	2.07 M	1.46 M	1.44 M	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-99.2 M	-88 M	-82 M	-37.9 M	-18.2 M	-	-	-	-	-	-	-	-
Interest Expense	762 K	-1.78 M	469 K	1.01 M	98 K	-	-	-	-	-	-	-	-
EBITDA	-97.9 M	-87.1 M	-81.4 M	-31.1 M	-17.8 M	-9.65 M	-6.96 M	-	-	-	-	-	-
Operating Expenses	101 M	89.5 M	83.5 M	37.9 M	18 M	9.76 M	6.99 M	-	-	-	-	-	-
General and Administrative Expenses	31.2 M	30.6 M	27.1 M	20.7 M	7.59 M	3.22 M	1.62 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Fusion Pharmaceuticals

	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	83.8 M	79.7 M	69.1 M	66.3 M	53.8 M	44.8 M	43.7 M	43.4 M	43.2 M	43.1 M	43 M	42.5 M	41.8 M	41.7 M	41.7 M	2.37 M	1.93 M	1.93 M	1.93 M	1.93 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-33.7 M	-	-17.3 M	-25.2 M	-24.3 M	-	-24 M	-19.1 M	-19.9 M	-	-19.4 M	-26.9 M	-17.5 M	-	-9.99 M	-44.7 M	-10.2 M	-	-594 K	-3.46 M	-3.93 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	2.01 M	34 K	28 K	-	166 K	570 K	585 K	-	325 K	521 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-35.9 M	-	-19.4 M	-26.7 M	-24.9 M	-	-23.8 M	-19.3 M	-20.5 M	-	-19.5 M	-27.3 M	-17.7 M	-	-10.3 M	-7.31 M	-8.7 M	-	-4.16 M	-3.91 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	297 K	-	391 K	80 K	-145 K	-	-1.16 M	-414 K	478 K	-	27 K	331 K	48 K	-	20 K	325 K	-197 K	-	-29 K	56 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-35.5 M	-	-	-	-24.6 M	-	-23.1 M	-18.9 M	-20.3 M	-	-19.1 M	-27 M	-17.6 M	-	-9.95 M	-7.04 M	-8.53 M	-	-3.95 M	-3.77 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	35.9 M	-	21.4 M	26.7 M	24.9 M	-	24 M	19.9 M	21.1 M	-	19.8 M	27.8 M	17.7 M	-	10.3 M	7.31 M	8.7 M	-	4.16 M	3.91 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	14.5 M	-	6.81 M	7.75 M	9.01 M	-	7.42 M	7.78 M	8.45 M	-	7.16 M	6.64 M	6.96 M	-	5.79 M	3.99 M	4.33 M	-	1.92 M	1.77 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency